SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GZMO
An SI Board Since November 1998
Posts SubjectMarks Bans Symbol
438 23 0 GZMO
Emcee:  mike mulhearn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
388Monday June 4, 8:53 am Eastern Time Press Release SOURCE: Genzyme Molecular Oncbetone-6/5/2001
387Strong contender for worst pun of the week - FRAMINGHAM, Mass., June 4 /PRNewswnigel bates-6/4/2001
386maybe this explains the recent rise in gzmo -- conference insiders buying stock:Extra Pale-5/31/2001
385<i>did the same</i> Let me know when you buy them back Stefaan.. :-nigel bates-5/29/2001
384Nig did the same :-) cheers Stefaan Perhaps some p53 news comming ?dalroi-5/29/2001
383What's with GZMO today ? I sold my small holding this afternoon, as these gunigel bates-5/29/2001
382Targeting Cancer Vaccines Cynthia Robbins-Roth, Forbes ASAP, 05.28.01 Genzyme MIcebrg-5/19/2001
381SAN DIEGO, April 11 /PRNewswire/ -- Invitrogen Corporation (Nasdaq: IVGN - news)nigel bates-4/12/2001
380Tuck, I don't know the answer to your question regarding how SAGE compares Extra Pale-4/8/2001
379I don't recall seeing this posted here; apologies if it has been: a review otuck-4/8/2001
378FRAMINGHAM, Mass., March 15 /PRNewswire/ -- Genzyme Molecular Oncology (Nasdaq: nigel bates-3/15/2001
377Notes from GZMO CC 3/8/01 Antigen discovery: - 10 cancer antigens discovered (PSpekulatius-3/9/2001
376Just to highlight the "clinical progress": Based on independent studikeokalani'nui-3/8/2001
375March 8 /PRNewswire/ -- Genzyme Corp. today reported that total revenues for Gennigel bates-3/8/2001
374article on vaccines, includes gzmo & some competing technologies. (thanks, tExtra Pale-3/8/2001
3732001 aacr.keokalani'nui-3/7/2001
372Should have posted this here, but brain hasn't been in gear recently - Messanigel bates-3/7/2001
371Wilder, are these recent abstracts?CChalmers-3/6/2001
370jeffrey, regrettably I can not answer that question. I posted the abstracts beckeokalani'nui-3/6/2001
369Wilder, I am not a scientist but have a little understanding of the subject. Thejeffbas-3/6/2001
368Vaccination of Allogeneic and Syngeneic Dendritic Cells Fusions with MUC1-Positikeokalani'nui-3/6/2001
367Induction of Specific Antitumor Immunity by CTL Generated from HLA-Matched and Ukeokalani'nui-3/6/2001
366Good question presented on RB. The results of this week's announcement abCChalmers-2/13/2001
365Dr. Singh is an old friend. We worked together at Max Planck Institute for Immuscaram(o)uche-2/5/2001
364Feb. 5, 2001--Imgenex Corp., a privately-held San Diego-based biotechnology compnigel bates-2/5/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News